Logo image of SAN.PA

SANOFI (SAN.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:SAN - FR0000120578 - Common Stock

81.63 EUR
-0.92 (-1.11%)
Last: 1/15/2026, 5:36:15 PM
Fundamental Rating

5

SAN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 53 industry peers in the Pharmaceuticals industry. SAN has a medium profitability rating, but doesn't score so well on its financial health evaluation. SAN has a decent growth rate and is not valued too expensively. SAN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • SAN had positive earnings in the past year.
  • Each year in the past 5 years SAN has been profitable.
  • Each year in the past 5 years SAN had a positive operating cash flow.
SAN.PA Yearly Net Income VS EBIT VS OCF VS FCFSAN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

  • With a decent Return On Assets value of 10.63%, SAN is doing good in the industry, outperforming 75.47% of the companies in the same industry.
  • SAN's Return On Equity of 18.84% is fine compared to the rest of the industry. SAN outperforms 64.15% of its industry peers.
  • With a decent Return On Invested Capital value of 13.40%, SAN is doing good in the industry, outperforming 66.04% of the companies in the same industry.
  • SAN had an Average Return On Invested Capital over the past 3 years of 7.31%. This is significantly below the industry average of 14.02%.
  • The 3 year average ROIC (7.31%) for SAN is below the current ROIC(13.40%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROIC 13.4%
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
SAN.PA Yearly ROA, ROE, ROICSAN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • With a decent Profit Margin value of 20.63%, SAN is doing good in the industry, outperforming 77.36% of the companies in the same industry.
  • In the last couple of years the Profit Margin of SAN has grown nicely.
  • Looking at the Operating Margin, with a value of 23.61%, SAN is in line with its industry, outperforming 56.60% of the companies in the same industry.
  • In the last couple of years the Operating Margin of SAN has grown nicely.
  • Looking at the Gross Margin, with a value of 72.29%, SAN is in line with its industry, outperforming 54.72% of the companies in the same industry.
  • SAN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
SAN.PA Yearly Profit, Operating, Gross MarginsSAN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

  • SAN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, SAN has about the same amount of shares outstanding.
  • SAN has about the same amout of shares outstanding than it did 5 years ago.
  • The debt/assets ratio for SAN has been reduced compared to a year ago.
SAN.PA Yearly Shares OutstandingSAN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
SAN.PA Yearly Total Debt VS Total AssetsSAN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • SAN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • SAN's Debt to Equity ratio of 0.18 is fine compared to the rest of the industry. SAN outperforms 79.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1.76
WACC7.63%
SAN.PA Yearly LT Debt VS Equity VS FCFSAN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 1.06 indicates that SAN should not have too much problems paying its short term obligations.
  • The Current ratio of SAN (1.06) is worse than 69.81% of its industry peers.
  • A Quick Ratio of 0.30 indicates that SAN may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.30, SAN is not doing good in the industry: 88.68% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.3
SAN.PA Yearly Current Assets VS Current LiabilitesSAN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

  • SAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.35%.
  • The Earnings Per Share has been growing slightly by 5.10% on average over the past years.
  • SAN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.56%.
  • Measured over the past years, SAN shows a small growth in Revenue. The Revenue has been growing by 3.31% on average per year.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.41% on average over the next years.
  • SAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.47% yearly.
EPS Next Y2.37%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
EPS Next 5Y7.41%
Revenue Next Year-0.09%
Revenue Next 2Y3.14%
Revenue Next 3Y4.36%
Revenue Next 5Y4.47%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SAN.PA Yearly Revenue VS EstimatesSAN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
SAN.PA Yearly EPS VS EstimatesSAN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

  • SAN is valuated reasonably with a Price/Earnings ratio of 10.74.
  • SAN's Price/Earnings ratio is rather cheap when compared to the industry. SAN is cheaper than 86.79% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of SAN to the average of the S&P500 Index (27.54), we can say SAN is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 9.60, the valuation of SAN can be described as reasonable.
  • SAN's Price/Forward Earnings ratio is rather cheap when compared to the industry. SAN is cheaper than 84.91% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.31. SAN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.74
Fwd PE 9.6
SAN.PA Price Earnings VS Forward Price EarningsSAN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SAN indicates a somewhat cheap valuation: SAN is cheaper than 69.81% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.01
SAN.PA Per share dataSAN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SAN does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of SAN may justify a higher PE ratio.
PEG (NY)4.53
PEG (5Y)2.11
EPS Next 2Y5.23%
EPS Next 3Y5.91%

8

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.73%, SAN is a good candidate for dividend investing.
  • SAN's Dividend Yield is rather good when compared to the industry average which is at 1.72. SAN pays more dividend than 90.57% of the companies in the same industry.
  • SAN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.
Industry RankSector Rank
Dividend Yield 4.73%

5.2 History

  • The dividend of SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
SAN.PA Yearly Dividends per shareSAN.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • SAN pays out 34.36% of its income as dividend. This is a sustainable payout ratio.
  • SAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.36%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
SAN.PA Yearly Income VS Free CF VS DividendSAN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
SAN.PA Dividend Payout.SAN.PA Dividend Payout, showing the Payout Ratio.SAN.PA Dividend Payout.PayoutRetained Earnings

SANOFI

EPA:SAN (1/15/2026, 5:36:15 PM)

81.63

-0.92 (-1.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-24
Earnings (Next)01-29
Inst Owners46.74%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap198.28B
Revenue(TTM)66.91B
Net Income(TTM)13.80B
Analysts79.31
Price Target106.44 (30.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.73%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.36%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.79%
Min EPS beat(2)-2.29%
Max EPS beat(2)5.86%
EPS beat(4)2
Avg EPS beat(4)1.85%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)5
Avg EPS beat(8)3.19%
EPS beat(12)7
Avg EPS beat(12)2.67%
EPS beat(16)11
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)4
Avg Revenue beat(12)9.01%
Revenue beat(16)8
Avg Revenue beat(16)21.12%
PT rev (1m)-1.1%
PT rev (3m)-2.94%
EPS NQ rev (1m)-1.79%
EPS NQ rev (3m)-10.16%
EPS NY rev (1m)-0.63%
EPS NY rev (3m)-1.68%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)-0.36%
Revenue NY rev (1m)-0.72%
Revenue NY rev (3m)0.33%
Valuation
Industry RankSector Rank
PE 10.74
Fwd PE 9.6
P/S 2.96
P/FCF N/A
P/OCF N/A
P/B 2.71
P/tB 45.1
EV/EBITDA 11.01
EPS(TTM)7.6
EY9.31%
EPS(NY)8.5
Fwd EY10.42%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.54
BVpS30.16
TBVpS1.81
PEG (NY)4.53
PEG (5Y)2.11
Graham Number71.82
Profitability
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROCE 16.17%
ROIC 13.4%
ROICexc 14.75%
ROICexgc 65.74%
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
FCFM N/A
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-ScoreN/A
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 0.68
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.3
Altman-Z N/A
F-ScoreN/A
WACC7.63%
ROIC/WACC1.76
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y2.37%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
EPS Next 5Y7.41%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year-0.09%
Revenue Next 2Y3.14%
Revenue Next 3Y4.36%
Revenue Next 5Y4.47%
EBIT growth 1Y9.12%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year29.1%
EBIT Next 3Y13.19%
EBIT Next 5Y10.5%
FCF growth 1Y-19.94%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y-11.47%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%

SANOFI / SAN.PA FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 5 / 10 to SAN.PA.


Can you provide the valuation status for SANOFI?

ChartMill assigns a valuation rating of 5 / 10 to SANOFI (SAN.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for SANOFI?

SANOFI (SAN.PA) has a profitability rating of 6 / 10.


What is the valuation of SANOFI based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SANOFI (SAN.PA) is 10.74 and the Price/Book (PB) ratio is 2.71.


How financially healthy is SANOFI?

The financial health rating of SANOFI (SAN.PA) is 3 / 10.